Orchestra BioMed Inc. (OBIO) PT Lowered to $9 at Jefferies

March 26, 2026 10:56 AM

Jefferies analyst Matthew Taylor lowered the price target on Orchestra BioMed Inc. (NASDAQ: OBIO) to $9.00 (from $10.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found